Clinical Trials Logo

Clinical Trial Summary

Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.


Clinical Trial Description

Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal and transabdominal techniques. The patients will receive only the NT information. Only in cases of detection of severe fetal anomalies the patient will get the information of the examination and counseling according to the findings. All patients will be asked to provide information of the 15 weeks early comprehensive ultrasound examination. The NT examination will be compared to the 15 weeks ultrasound. All patients will be asked to give information after delivery of the baby's health condition. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00943189
Study type Observational
Source Sheba Medical Center
Contact Liat Gindes, MD
Email gindesl@smile.net.il
Status Recruiting
Phase N/A
Start date June 2008

See also
  Status Clinical Trial Phase
Recruiting NCT03514940 - Perinatal Diagnosis of GIT Anomalies
Recruiting NCT02744365 - Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications